Articles On Race Oncology (ASX:RAC)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Health: Orthocell’s technology could be even more powerful than first thought
Remember Orthocell (ASX: OCC), that company gained 377 per cent in a day when it showed Cel-Gro helped patients with nerve damage regain sensation? It could be even more powerful than it showed then. While indeed, the trial showed it helpe... |
Stockhead | RAC | 6 years ago |
|
Top 10 at 10: These ASX stocks are launching higher this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel... |
Stockhead | RAC | 6 years ago |
|
First patient treated in Race Oncology trial
“This is a major milestone for Race, because it’s the first treatment with Bisantrene since the drug disappeared more than 25 years ago,” said CEO Peter Molloy. |
BiotechDispatch | RAC | 6 years ago |
|
Trading Places: Retail investors may be ‘tax-loss’ selling but fund managers are buying
In this week’s recap of substantial holder movements four substantial holders bought shares in Zenith Energy (ASX:ZEN), a Shanghai investor bought into Anson Resources (ASX:ASN) and Sirtex’s founder bought into Syrah Resources (ASX:SYR). Su... |
Stockhead | RAC | 6 years ago |